Related references
Note: Only part of the references are listed.Cancer Cell-derived Secretory Factors in Breast Cancer-associated Lung Metastasis: Their Mechanism and Future Prospects
Tabinda Urooj et al.
CURRENT CANCER DRUG TARGETS (2020)
Circular RNA hsa_circRNA_002178 silencing retards breast cancer progression via microRNA-328-3p-mediated inhibition of COL1A1
Ting Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
The prognostic and predictive potential of Ki-67 in triple-negative breast cancer
Xiuzhi Zhu et al.
SCIENTIFIC REPORTS (2020)
Risk of breast cancer-related death in women with a prior cancer
Fei Ji et al.
AGING-US (2020)
miR-328-3p mediates the anti-tumor effect in osteosarcoma via directly targeting MMP-16
Jianhui Shi et al.
CANCER CELL INTERNATIONAL (2019)
Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p
Bin Xiao et al.
BMC CANCER (2019)
Changes in the Ki-67 labeling index between primary breast cancer and metachronous metastatic axillary lymph node: A retrospective observational study
Naoya Ishibashi et al.
THORACIC CANCER (2019)
Prognostic role of microRNAs in breast cancer: A systematic review
Eleni Zografos et al.
Oncotarget (2019)
Ki-67/MKI67 as a Predictive Biomarker for Clinical Outcome in Gastric Cancer Patients: an Updated Meta-analysis and Systematic Review involving 53 Studies and 7078 Patients
Dan-dan Xiong et al.
JOURNAL OF CANCER (2019)
MiR-519d-3p suppresses breast cancer cell growth and motility via targeting LIM domain kinase 1
Dengfeng Li et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2018)
MiR-519d suppresses breast cancer tumorigenesis and metastasis via targeting MMP3
Chengling Chu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial-mesenchymal transition
Yue Yu et al.
MOLECULAR CANCER (2018)
Augmented expression of Ki-67 is correlated with clinicopathological characteristics and prognosis for lung cancer patients: an up-dated systematic review and meta-analysis with 108 studies and 14,732 patients
Dan-ming Wei et al.
RESPIRATORY RESEARCH (2018)
High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers
Cecilia Ahlin et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Distribution of Ki-67 values within HER2 & ER/PgR expression variants of ductal breast cancers as a potential link between IHC features and breast cancer biology
Sven Kurbel et al.
BMC CANCER (2017)
Evaluation of Tumor Cell Proliferation by Ki-67 Expression and Mitotic Count in Lymph Node Metastases from Breast Cancer
Sura Aziz et al.
PLOS ONE (2016)
Ki-67 is a Valuable Prognostic Factor in Gliomas: Evidence from a Systematic Review and Meta-analysis
Wen-Jie Chen et al.
Asian Pacific Journal of Cancer Prevention (2015)
miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression
Xin Deng et al.
ONCOLOGY REPORTS (2015)
High Serum miR-19a Levels Are Associated with Inflammatory Breast Cancer and Are Predictive of Favorable Clinical Outcome in Patients with Metastatic HER2+ Inflammatory Breast Cancer
Simone Anfossi et al.
PLOS ONE (2014)
Identifying Ki-67 specific miRNA-MRNA interactions in malignant astrocytomas
Yanwei Liu et al.
NEUROSCIENCE LETTERS (2013)
MicroRNA-519d targets MKi67 and suppresses cell growth in the hepatocellular carcinoma cell line QGY-7703
Yan-Yan Hou et al.
CANCER LETTERS (2011)
Share Paper
